T. Rowe Price Health Sciences Fund

Class No Load (PRHSX)
Scorecard
5 / 5 Stars
Lipper
5 5 5 5 3
Zacks Investment Research
4 (Sell)
Standard & Poor's
4 / 5 Stars
TheStreet.com
A (Buy)

Fund Holdings

Asset Allocation

% Long % Net
Cash 2.29 2.29
Stocks 84.04 84.04
Bonds 0.0 0.0
Other 0.25 0.25
Foreign Bonds 0.0 0.0
Foreign Stocks 13.39 13.39
Convertible 0.03 0.03
Preferred 0.0 0.0

Updated 12.31.2013

Top 10 Holdings

Performance as of 02.28.2014

Portfolio as of 12.31.2013

Ticker YTD Return % % Net Assets
Gilead Sciences Inc GILD 8.46 7.59
Alexion Pharmaceuticals, Inc. ALXN 29.76 4.52
Biogen Idec Inc BIIB 21.04 3.13
UnitedHealth Group Inc UNH 2.39 2.97
Valeant Pharmaceuticals International Inc VRX 22.13 2.95
Agilent Technologies Inc A -0.84 2.88
Incyte Corp Ltd INCY 25.91 2.86
McKesson Corp MCK 9.23 2.65
Pharmacyclics, Inc. PCYC 29.76 2.53
AbbVie Inc ABBV -4.39 2.28